Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press65210.17650/1726-9776-2017-13-3-124-131REVIEWОБЗОРIs there an association between prostate cancer and human papillomaviruses? Returning to the unresolved problemАссоциирован ли рак предстательной железы с вирусами папилломы человека? Возвращаясь к нерешенной проблемеVolgarevaG. M.ВолгареваГ. М.
Russian Federation

24 Kashirskoe Shosse, Moscow 115478, Russia

ведущий научный сотрудник, лаб. механизмов гибели опухолевых клеток НИИ Канцерогенеза,доктор биологических наук, доцент

Россия, 115478 Москва, Каширское шоссе, 24

galina.volgareva@yandex.ruN. N. Blokhin National Medical Research Oncology Center, Ministry of Health of RussiaФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава России300920171331241313101201724082017https://oncourology.abvpress.ru/oncur/article/view/652

Prostate cancer morbidity and mortality rates are steadily increasing in Russia and the world. The etiology of this cancer has not been adequately studied. In particular, the role of high-risk human papillomavirus types that are potent biological carcinogens in a number of other human organs remains unclear. Different laboratories worldwide continue to provide information, the authors of which make mutually exclusive conclusions regarding the involvement of these viruses in the genesis of prostate cancer. This review contains an analysis of the data available in the literature on the possible involvement of human papillomaviruses in prostate cancer.

Заболеваемость раком предстательной железы и смертность от данного заболевания неуклонно возрастают. Этиология этой формы рака недостаточно изучена. Остается неясной роль вирусов папилломы человека типов высокого онкогенного риска, которые в ряде других органов человека являются сильными биологическими канцерогенами. Продолжают появляться сообщения из разных лабораторий мира, авторы которых делают взаимоисключающие выводы относительно участия этих вирусов в генезе рака предстательной железы. Обзор содержит анализ данных литературы, опубликованных преимущественно в последние годы, о возможном участии вирусов папилломы человека в возникновении рака предстательной железы.

prostatecancerhuman papillomavirusпредстательная железараквирус папилломы человека1. Torre L. A., Siegel R. L., Ward E. M., Jemal A. Global cancer incidence and mortality rates and trends – an update. Cancer Epidemiol Biomarkers Prev 2016;25(1):16–27. DOI: 10.1158/1055–9965.EPI-15–0578. PMID: 26667886.Torre L. A., Siegel R. L., Ward E. M., Jemal A. Global cancer incidence and mortality rates and trends – an update. Cancer Epidemiol Biomarkers Prev 2016;25(1):16–27. DOI: 10.1158/1055–9965.EPI-15–0578. PMID: 26667886.2. Имянитов Е. Н. Эпидемиология и биология рака простаты. Практическая онкология 2008;9(2):57–64. [Imyaitov E. N. Epidemiology and biology of prostate cancer. Prakticheskaya onkologiya = Practical Oncology 2008;9(2):57–64. (In Russ.)].Имянитов Е. Н. Эпидемиология и биология рака простаты. Практическая онкология 2008;9(2):57–64. [Imyaitov E. N. Epidemiology and biology of prostate cancer. Prakticheskaya onkologiya = Practical Oncology 2008;9(2):57–64. (In Russ.)].3. Schröder F. H., Roobol M. J. Prostate cancer epidemic in sight? Eur Urol 2012;61(6):1093– 5. DOI: 10.1016/j.eururo.2012.03.019. PMID: 22464308.Schröder F. H., Roobol M. J. Prostate cancer epidemic in sight? Eur Urol 2012;61(6):1093– 5. DOI: 10.1016/j.eururo.2012.03.019. PMID: 22464308.4. Злокачественные новообразования в России в 2014 году (заболеваемость и смертность). Под ред. А. Д. Каприна, В. В. Старинского, Г. В. Петровой. М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2016. 250 с. [Malignant tumors in Russia in 2015 (morbidity and fatality). Eds.: А. D. Kaprin, V. V. Starinskiy, G. V. Petrova. Moscow: MNIOI im. P. A. Gertsena – filial FGBU “NMIRTS” Minzdrava Rossii, 2017. 250 p. (In Russ.)].Злокачественные новообразования в России в 2014 году (заболеваемость и смертность). Под ред. А. Д. Каприна, В. В. Старинского, Г. В. Петровой. М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2016. 250 с. [Malignant tumors in Russia in 2015 (morbidity and fatality). Eds.: А. D. Kaprin, V. V. Starinskiy, G. V. Petrova. Moscow: MNIOI im. P. A. Gertsena – filial FGBU “NMIRTS” Minzdrava Rossii, 2017. 250 p. (In Russ.)].5. Заридзе Д. Г. Профилактика рака. М.: ИМА-ПРЕСС, 2009. 224 с. [Zaridze D. G. Prophylaxis of cancer. Мoscow: IMA-PRESS, 2009. 224 p. (In Russ.)].Заридзе Д. Г. Профилактика рака. М.: ИМА-ПРЕСС, 2009. 224 с. [Zaridze D. G. Prophylaxis of cancer. Мoscow: IMA-PRESS, 2009. 224 p. (In Russ.)].6. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2(5): 342–50. DOI: 10.1038/nrc798. PMID: 12044010.zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2(5): 342–50. DOI: 10.1038/nrc798. PMID: 12044010.7. zur Hausen H. To vaccination and beyond. Biochemistry (Mosc) 2008;73(5):498–503. PMID: 18605974.zur Hausen H. To vaccination and beyond. Biochemistry (Mosc) 2008;73(5):498–503. PMID: 18605974.8. Hrbacek J., Urban M., Hamsikova E. et al. Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case- control study. BMC Cancer 2011;3(11):53. DOI: 10.1186/1471-2407-11-53. PMID: 21291519.Hrbacek J., Urban M., Hamsikova E. et al. Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case- control study. BMC Cancer 2011;3(11):53. DOI: 10.1186/1471-2407-11-53. PMID: 21291519.9. IARC Monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses. Lyon, 2007. Vol. 90. 689 p.IARC Monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses. Lyon, 2007. Vol. 90. 689 p.10. IARC Monographs on the evaluation of carcinogenic risks to humans. A review of human carcinogens. Part B. Biological agents. Lyon, 2011. Vol. 100. 502 p.IARC Monographs on the evaluation of carcinogenic risks to humans. A review of human carcinogens. Part B. Biological agents. Lyon, 2011. Vol. 100. 502 p.11. Ruijter E., van de Kaa C., Miller G. et al. Molecular genetics and epidemiology of prostate carcinoma. Endocr Rev 1999;20(1):22–45. DOI: 10.1210/edrv.20.1.0356. PMID: 10047972.Ruijter E., van de Kaa C., Miller G. et al. Molecular genetics and epidemiology of prostate carcinoma. Endocr Rev 1999;20(1):22–45. DOI: 10.1210/edrv.20.1.0356. PMID: 10047972.12. Zambrano A., Kalantari M., Simoneau A. et al. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 2002;53(4):263–76. DOI: 10.1002/pros.10157. PMID: 12430138.Zambrano A., Kalantari M., Simoneau A. et al. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 2002;53(4):263–76. DOI: 10.1002/pros.10157. PMID: 12430138.13. Taylor M. L., Mainous A. G., Wells B. J. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med 2005;37(7):506–12. PMID: 15988645.Taylor M. L., Mainous A. G., Wells B. J. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med 2005;37(7):506–12. PMID: 15988645.14. Волгарева Г.М. Ассоциирован ли рак предстательной железы с вирусами папилломы человека? Российский биотерапевтический журнал 2017;16(2):6–12. [Volgareva G.M. Is there an association between prostate cancer and human papillomaviruses? Russiyskiy bioterapevticheskiy zhurnal = Journal of Biotherapy 2017;16(2):6–12. (In Russ.)]. DOI: 10.17650/1726-9776-2017-13-3-00-00.Волгарева Г.М. Ассоциирован ли рак предстательной железы с вирусами папилломы человека? Российский биотерапевтический журнал 2017;16(2):6–12. [Volgareva G.M. Is there an association between prostate cancer and human papillomaviruses? Russiyskiy bioterapevticheskiy zhurnal = Journal of Biotherapy 2017;16(2):6–12. (In Russ.)]. DOI: 10.17650/1726-9776-2017-13-3-00-00.15. Kasiske B. L., Snyder J. J., Gilbertson D. T., Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004;4(6):905–13. DOI: 10.1111/j.1600-6143.2004.00450.x. PMID: 15147424.Kasiske B. L., Snyder J. J., Gilbertson D. T., Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004;4(6):905–13. DOI: 10.1111/j.1600-6143.2004.00450.x. PMID: 15147424.16. Grulich A. E., van Leeuwen M. T., Falster M. O., Vajdic C. M. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370(9581):59–67. DOI: 10.1016/S0140–6736(07)61050–2. PMID: 17617273.Grulich A. E., van Leeuwen M. T., Falster M. O., Vajdic C. M. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370(9581):59–67. DOI: 10.1016/S0140–6736(07)61050–2. PMID: 17617273.17. Collett D., Mumford L., Banner N. R. et al. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 2010;10(8):1889–96. DOI: 10.1111/j.1600–6143.2010.03181.x. PMID: 20659094.Collett D., Mumford L., Banner N. R. et al. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 2010;10(8):1889–96. DOI: 10.1111/j.1600–6143.2010.03181.x. PMID: 20659094.18. Engels E. A., Pfeiffer R. M., Fraumeni J. F. Jr et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011;306(17):1891–901. DOI: 10.1001/jama.2011.1592. PMID: 22045767.Engels E. A., Pfeiffer R. M., Fraumeni J. F. Jr et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011;306(17):1891–901. DOI: 10.1001/jama.2011.1592. PMID: 22045767.19. Leiros G. J., Galliano S. R., Sember M. E. et al. Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol 2005;24(5):15. DOI: 10.1186/1471-2490-5-15. PMID: 16307686.Leiros G. J., Galliano S. R., Sember M. E. et al. Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol 2005;24(5):15. DOI: 10.1186/1471-2490-5-15. PMID: 16307686.20. Martinez-Fierro M. L., Leach R. J., Gomez-Guerra L. S. et al. Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer 2010;10:326. DOI: 10.1186/1471-2407-10-326. PMID: 20576103.Martinez-Fierro M. L., Leach R. J., Gomez-Guerra L. S. et al. Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer 2010;10:326. DOI: 10.1186/1471-2407-10-326. PMID: 20576103.21. Deschoolmeester V., van Marck V., Baay M. et al. Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. BMC Cancer 2010;10:117. DOI: 10.1186/1471-2407-10- 117. PMID: 20346145.Deschoolmeester V., van Marck V., Baay M. et al. Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. BMC Cancer 2010;10:117. DOI: 10.1186/1471-2407-10- 117. PMID: 20346145.22. Golovina D. A., Trofimova O. B., Ermilova V. D. et al. Complex of molecular genetic and immunohistochemical methods for detection of human papillomavirus in the bladder cancer epithelium. Bull Exp Biol Med 2014;157(1):70–3. DOI: 10.1007/s10517-014-2494-0. PMID: 24909719.Golovina D. A., Trofimova O. B., Ermilova V. D. et al. Complex of molecular genetic and immunohistochemical methods for detection of human papillomavirus in the bladder cancer epithelium. Bull Exp Biol Med 2014;157(1):70–3. DOI: 10.1007/s10517-014-2494-0. PMID: 24909719.23. Smelov V., Eklund C., Bzhalava D. et al. Expressed prostate secretions in the study of human papillomavirus epidemiology in the male. PLoS One 2013;8(6):625–30. DOI: 10.1371/journal.pone.0066630. PMID: 23799125.Smelov V., Eklund C., Bzhalava D. et al. Expressed prostate secretions in the study of human papillomavirus epidemiology in the male. PLoS One 2013;8(6):625–30. DOI: 10.1371/journal.pone.0066630. PMID: 23799125.24. Singh N., Hussain S., Kakkar N. et al. Implication of high risk human papillomavirus HR- HPV infection in prostate cancer in Indian population – a pioneering case-control analysis. Sci Rep 2015;5:7822. DOI: 10.1038/srep07822. PMID: 25592643.Singh N., Hussain S., Kakkar N. et al. Implication of high risk human papillomavirus HR- HPV infection in prostate cancer in Indian population – a pioneering case-control analysis. Sci Rep 2015;5:7822. DOI: 10.1038/srep07822. PMID: 25592643.25. Yow M. A., Tabrizi S. N., Severi G. et al. Detection of infectious organisms in archival prostate cancer tissues. BMC Cancer 2014;14:579. DOI: 10.1186/1471-2407-14-579. PMID: 25106851.Yow M. A., Tabrizi S. N., Severi G. et al. Detection of infectious organisms in archival prostate cancer tissues. BMC Cancer 2014;14:579. DOI: 10.1186/1471-2407-14-579. PMID: 25106851.26. Yow M. A., Tabrizi S. N., Severi G. et al. Characterization of microbial communities with aggressive prostate cancer tissues. Infect Agent Cancer 2017;12:4. DOI: 10.1186/s13027- 016-0112-7. PMID: 28101126.Yow M. A., Tabrizi S. N., Severi G. et al. Characterization of microbial communities with aggressive prostate cancer tissues. Infect Agent Cancer 2017;12:4. DOI: 10.1186/s13027- 016-0112-7. PMID: 28101126.27. Pascale M., Pracella D., Barbazza R. et al. Is human papillomavirus associated with prostate cancer survival? Dis Markers 2013;35(6):607–13. DOI: 10.1155/2013/735843. PMID: 24288430.Pascale M., Pracella D., Barbazza R. et al. Is human papillomavirus associated with prostate cancer survival? Dis Markers 2013;35(6):607–13. DOI: 10.1155/2013/735843. PMID: 24288430.28. Faoro V., Barbazza R., Bonin S. et al. Detection of HPV E7 oncoviral protein in cervical lesions by a new antibody. Appl Immunohistochem Mol Morphol 2013;21(4);341–50. DOI: 10.1097/PAI. 0b013e318269bf5d. PMID: 22935825.Faoro V., Barbazza R., Bonin S. et al. Detection of HPV E7 oncoviral protein in cervical lesions by a new antibody. Appl Immunohistochem Mol Morphol 2013;21(4);341–50. DOI: 10.1097/PAI. 0b013e318269bf5d. PMID: 22935825.29. Montironi R., Mazzuccheli R., Scarpelli M. et al. Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sourses of pathology discrepancies. BJU Int 2005;95(8):1146–52. DOI: 10.1111/j. 1464-410X.2005.05540.x. PMID: 15877724.Montironi R., Mazzuccheli R., Scarpelli M. et al. Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sourses of pathology discrepancies. BJU Int 2005;95(8):1146–52. DOI: 10.1111/j. 1464-410X.2005.05540.x. PMID: 15877724.30. Thompson I. M., Ankerst D. P., Chi C. et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2006;98(8):529–34. DOI: 10.1093/jnci/djj131. PMID: 16622122.Thompson I. M., Ankerst D. P., Chi C. et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2006;98(8):529–34. DOI: 10.1093/jnci/djj131. PMID: 16622122.31. Dillner J., Knekt P., Boman J. et al. Seroepidemiological association between human- papillomavirus infection and risk of prostate cancer. Int J Cancer 1998;75(4):564–7. PMID: 9466657.Dillner J., Knekt P., Boman J. et al. Seroepidemiological association between human- papillomavirus infection and risk of prostate cancer. Int J Cancer 1998;75(4):564–7. PMID: 9466657.32. Adami H. O., Kuper H., Andersson S. O. et al. Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case control study. Cancer Epidemol Biomarkers Prev 2003;12(9):872–5. PMID: 14504197.Adami H. O., Kuper H., Andersson S. O. et al. Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case control study. Cancer Epidemol Biomarkers Prev 2003;12(9):872–5. PMID: 14504197.33. Korodi Z., Dillner J., Jellum E. et al. Human papillomavirus 16, 18 and 33 infections and risk of prostate cancer: a Nordic nested case control study. Cancer Epidemiol Biomarkers Prev 2005;14(12):2952–5. DOI: 10.1158/1055–9965.EPI-05–0602. PMID: 16365015.Korodi Z., Dillner J., Jellum E. et al. Human papillomavirus 16, 18 and 33 infections and risk of prostate cancer: a Nordic nested case control study. Cancer Epidemiol Biomarkers Prev 2005;14(12):2952–5. DOI: 10.1158/1055–9965.EPI-05–0602. PMID: 16365015.34. Sitas F., Urban M., Stein L. et al. The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population. Infect Agent Cancer 2007;2:6. DOI: 10.1186/1750-9378-2-6. PMID: 17331260.Sitas F., Urban M., Stein L. et al. The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population. Infect Agent Cancer 2007;2:6. DOI: 10.1186/1750-9378-2-6. PMID: 17331260.35. Sutcliffe S., Viscidi R. P., Till C. et al. Human papillomavirus types 16, 18 and 31 serostatus and prostate cancer risk in the Prostate Cancer Trial. Cancer Epidemiol Biomarkers Prev 2010;19(2):614–8. DOI: 10.1158/1055–9965.EPI-09–1080. PMID: 20142255.Sutcliffe S., Viscidi R. P., Till C. et al. Human papillomavirus types 16, 18 and 31 serostatus and prostate cancer risk in the Prostate Cancer Trial. Cancer Epidemiol Biomarkers Prev 2010;19(2):614–8. DOI: 10.1158/1055–9965.EPI-09–1080. PMID: 20142255.36. Franco E. L., Villa L. L., Sobrinho J. P. et al. Epidemiology of acquisition and clearance of cervical human papilloma infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180(5):1415–23. DOI: 10.1086/315086. PMID: 10515798.Franco E. L., Villa L. L., Sobrinho J. P. et al. Epidemiology of acquisition and clearance of cervical human papilloma infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180(5):1415–23. DOI: 10.1086/315086. PMID: 10515798.37. Zumbach K., Kisseljov F., Sacharova O. et al. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia. Int J Cancer 2000;85(3):313–8. PMID: 10652419.Zumbach K., Kisseljov F., Sacharova O. et al. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia. Int J Cancer 2000;85(3):313–8. PMID: 10652419.38. Gillison M. L., Shah K. V. Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 2003;31:57–65. PMID: 12807947.Gillison M. L., Shah K. V. Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 2003;31:57–65. PMID: 12807947.39. Weijerman P. C., König J. J., Wong S. T. et al. Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res 1994;54(21):5579–83. PMID: 7923200.Weijerman P. C., König J. J., Wong S. T. et al. Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res 1994;54(21):5579–83. PMID: 7923200.40. Weijerman P. C., van Drunen E., König J. J. et al. Specific cytogenetic aberrations in two novel human prostatic cell lines immortalized by human papillomavirus type 18 DNA. Cancer Genet Cytoge net 1997;99(2):108–15. PMID: 9398864.Weijerman P. C., van Drunen E., König J. J. et al. Specific cytogenetic aberrations in two novel human prostatic cell lines immortalized by human papillomavirus type 18 DNA. Cancer Genet Cytoge net 1997;99(2):108–15. PMID: 9398864.41. Weijerman P. C., Zhang Y., Shen J. et al. Expression of prostatic factors measured by reverse transcription polymerase chain reaction in human papillomavirus type 18 deoxyribonucleic acid immortalized prostate cell lines. Urology 1998;51(4):657–62. PMID: 9586625.Weijerman P. C., Zhang Y., Shen J. et al. Expression of prostatic factors measured by reverse transcription polymerase chain reaction in human papillomavirus type 18 deoxyribonucleic acid immortalized prostate cell lines. Urology 1998;51(4):657–62. PMID: 9586625.42. Hartwig S., Syrjanen S., Dominiak-Felden G. et al. Estimation of the epidemiological burden of human papillomavirusrelated cancers and nonmalignant diseases in men in Europe. BMC Cancer 2012;12:30. DOI: 10.1186/1471-2407-12-30. PMID: 22260541.Hartwig S., Syrjanen S., Dominiak-Felden G. et al. Estimation of the epidemiological burden of human papillomavirusrelated cancers and nonmalignant diseases in men in Europe. BMC Cancer 2012;12:30. DOI: 10.1186/1471-2407-12-30. PMID: 22260541.43. Reiter P. L., Pendergraft W. F., Brewer N. T. Meta-analysis of human papillomavirus infection concordance. Cancer Epidemiol Biomarkers Prev 2010;19(11):2916–31. DOI: 10.1158/1055-9965.EPI-10-0576. PMID: 20833971.Reiter P. L., Pendergraft W. F., Brewer N. T. Meta-analysis of human papillomavirus infection concordance. Cancer Epidemiol Biomarkers Prev 2010;19(11):2916–31. DOI: 10.1158/1055-9965.EPI-10-0576. PMID: 20833971.44. de Lima Rocha M. G., Faria F. L., Goncalves L. et al. Prevalence of DNA-HPV in male sexual partners of HPV infected women and concordance of viral types in infected couples. PLoS One 2012;7(7):40988. DOI: 10.1371/journal.pone.0040988. PMID: 22815888.de Lima Rocha M. G., Faria F. L., Goncalves L. et al. Prevalence of DNA-HPV in male sexual partners of HPV infected women and concordance of viral types in infected couples. PLoS One 2012;7(7):40988. DOI: 10.1371/journal.pone.0040988. PMID: 22815888.45. Foresta C., Garolla A., Zuccarello D. et al. Human papillomavirus found in sperm head of young adult males affects the progressive motility. Fertil Steril 2010;93(3):802–6. DOI: 10.1016/j.fertnstert.2008.10.050. PMID: 19100537.Foresta C., Garolla A., Zuccarello D. et al. Human papillomavirus found in sperm head of young adult males affects the progressive motility. Fertil Steril 2010;93(3):802–6. DOI: 10.1016/j.fertnstert.2008.10.050. PMID: 19100537.46. Foresta C., Patassini C., Bertoldo A. et al. Mechanism of human papillomavirus binding to human spermatozoa and fertilizing ability of infected spermatozoa. PLoS One 2011;6(3):15036. DOI: 10.1371/journal.pone.0015036. PMID: 21408100.Foresta C., Patassini C., Bertoldo A. et al. Mechanism of human papillomavirus binding to human spermatozoa and fertilizing ability of infected spermatozoa. PLoS One 2011;6(3):15036. DOI: 10.1371/journal.pone.0015036. PMID: 21408100.47. Yang Y., Jia C. W., Ma Y. M. et al. Correlation between HPV sperm infection and male infertility. Asian J Androl 2013;15(4):529–32. DOI: 10.1038/aja.2013.3647. PMID: 23603919.Yang Y., Jia C. W., Ma Y. M. et al. Correlation between HPV sperm infection and male infertility. Asian J Androl 2013;15(4):529–32. DOI: 10.1038/aja.2013.3647. PMID: 23603919.48. Yang L., Xie S., Feng X. et al. Worldwide prevalence of human papillomavirus and relative risk of prostate cancer: a meta-analysis. Sci Rep 2015;5:14667. DOI: 10.1038/srep14667. PMID: 26441160.Yang L., Xie S., Feng X. et al. Worldwide prevalence of human papillomavirus and relative risk of prostate cancer: a meta-analysis. Sci Rep 2015;5:14667. DOI: 10.1038/srep14667. PMID: 26441160.